In vitro evaluation of CM 40876, a new third-generation cephalosporin
Raimondi, A.; Cocuzza, C.; Musmanno, G.; Mattina, R.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 6(2): 103-106
1987
ISSN/ISBN: 0392-906X PMID: 3509932 Document Number: 296695
Document emailed within 1 workday
Related Documents
Iakovlev, V.P. 1994: Cefodizime--a new 3rd generation cephalosporin antibiotic for parenteral use Antibiotiki i Khimioterapiia 39(12): 35-51Iakovlev, V.P.; Levshin, I.B. 1996: A new fourth generation cephalosporin antibiotic--cefpirome Antibiotiki i Khimioterapiia 41(12): 5-6
Beloborodova, N.V. 2001: A fourth generation cephalosporin--cefepime (maxipime) in pediatrics Antibiotiki i Khimioterapiia 46(9): 19-25
Gökalp, A.S.; Oğuz, A.; Gültekin, A.; Içağasioğlu, D. 1991: Neonatal sepsis in Turkey: the comparison between penicillin plus aminoglycoside and ampicillin plus third-generation cephalosporin chemotherapies Materia Medica Polona. Polish Journal of Medicine and Pharmacy 23(3): 226-228
Cereda; Sader; Barth; Segura; Kage; Novakonski; Pignatari 1999: Evaluation of the in vitro Activity of two Fourth-Generation Cephalosporins Against Bacterial Samples Isolated from Patients in Several Brazilian Hospitals Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(5): 189-196
Qadri, S.M.; Ayub, A.; Ueno, Y.; Saldin, H. 1992: Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety Clinical Therapeutics 14(4): 562-569
Singhvi, S.M.; Heald, A.F.; Gadebusch, H.H.; Resnick, M.E.; Difazio, L.T.; Leitz, M.A. 1977: Human serum protein binding of cephalosporin antibiotics in vitro Journal of Laboratory and Clinical Medicine 89(2): 414-420
Mészáros, J.; Tołłoczko, T.; Stachlewska, E.; Tyc, Z.; Jeljaszewicz, J. 1989: Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. the choice of cephalosporin Journal of ChemoTherapy 1(4 Suppl): 828-829
Yourassowsky, E.; Schoutens, E. 1975: In vitro bacteriostatic and bactericidal activities of 7 cephalosporin antibiotics on Haemophilus influenzae International Journal of Clinical Pharmacology and Biopharmacy 12(4): 433-436
Punpanich, W.; Tantichattanon, W.; Wongwatcharapaiboon, S.; Treeratweeraphong, V. 2008: In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria Journal of the Medical Association of Thailand 91(Suppl 3): S21-S27
Korting, H.C. 1984: Cephalosporin allergy and cephalosporin-penicillin cross allergies with special reference to venereologic therapy of severe anaphylactic reactions Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 35(5): 225-229
Soussy, C.J.; Meyran, M.; Chanal, M.; Reverdy, M.E.; Kitzis, M.D.; Derlot, E. 1991: In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study Pathologie-Biologie 39(5): 396-402
Chin, N.X.; Neu, H.C. 1987: In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(5): 329-336
Susan, M.; Hariharan, T.S.; Sonya, J. 2013: A comparative in vitro study of cephalosporin/beta-lactamase inhibitor combinations against gram negative bacilli Indian Journal of Physiology and Pharmacology 57(4): 425-431
Chantot, J.F.; Mauvais, P. 1991: RU 51807 (cefpodoxime proxetil). in vitro and in vivo antibacterial activity of a new orally administered active cephalosporin Pathologie-Biologie 39(1): 17-27
Goitre, M.; Bedello, P.G. 1982: Clinical evaluation of a new cephalosporin for oral use in dermatology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 117(4): Xlix
Blandino, G.; Dubini, F.; Russo, G.; Cocuzza, G. 1980: Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin Clinical Therapeutics 3(Spec Issue): 103-111
Mawas, C.; Sasportes, M.; Charmot, D.; Christen, Y.; Dausset, J. 1975: Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases Clinical and Experimental Immunology 20(1): 83-92
Magri, M. 1976: Clinical evaluation of a new oral cephalosporin (cephalexin pivaloxymethyl ester) in pediatric otorhinolaryngology La Clinica Terapeutica 78(5): 421-434
Hancock, R.E.; Bellido, F. 1996: Antibacterial in vitro activity of fourth generation cephalosporins Journal of ChemoTherapy 8(Suppl): 31-36